Skip to content

PROCESS. TECHNOLOGY. EXPERIENCE.

Quality Solutions Now (QSN) LogoQuality Solutions Now (QSN) Logo
  • Home
  • What We Do
    • How We Make An Impact
    • What Our Clients Say
    • QSN Supplier Listings
  • Our Proprietary Process
  • Our Skilled Consultants
    • Become a QSN Consultant
  • News and Advice
  • Contact
  • FDA to Phase Out Animal Testing Requirements, Promising Accelerated Cures and Smarter Drug Development

    In April 2025, the U.S. Food and Drug Administration (FDA) unveiled their roadmap designed to reduce, refine, and potentially replace animal testing, beginning with monoclonal antibody therapies and expanding to other drug modalities. This marks [...]

  • FDA Issues Draft Guidance on 510(k) Transfer Protocols for Biotech and MedTech Firms

    In June 2025, the U.S. Food and Drug Administration (FDA) issued a long-anticipated draft guidance that clarifies the process for transferring ownership of 510(k) clearances. The document: “Transfer of a Premarket Notification (510(k)) Clearance” addresses [...]

  • Trump Grants Two-Year Delay for EtO Compliance: What It Means for Medical Device Manufacturers

    On July 17, 2025, President Donald Trump issued an executive order granting 39 medical device sterilization facilities a two-year extension to comply with new ethylene oxide (EtO) emissions limits. This move follows months of industry [...]

  • FDA Launches Communications Pilot to Accelerate High-Risk Medical Device Recall Notifications

    In a move aimed at strengthening patient safety and enhancing transparency, the FDA’s Center for Devices and Radiological Health (CDRH) has announced a new communications pilot program that seeks to reduce the time between the [...]

© 2012 - 2025 • Avada is a Website Builder for WordPress and eCommerce • All Rights Reserved • Developed by ThemeFusion

Page load link
Go to Top